Search results for "Immunity"

showing 10 items of 1537 documents

IAP proteins as targets for drug development in oncology

2013

Laurence Dubrez,1,2 Jean Berthelet,1,2 Valérie Glorian,1,21Institut National de la Santé et de la Recherche Médicale (Inserm), Dijon, France; 2Université de Bourgogne, Dijon, FranceAbstract: The inhibitors of apoptosis (IAPs) constitute a family of proteins involved in the regulation of various cellular processes, including cell death, immune and inflammatory responses, cell proliferation, cell differentiation, and cell motility. There is accumulating evidence supporting IAP-targeting in tumors: IAPs regulate various cellular processes that contribute to tumor development, such as cell death, cell proliferation, and cell migration; their expressio…

body regionsbiological phenomena cell phenomena and immunityOncoTargets and TherapyOncoTargets and Therapy
researchProduct

The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs

2021

Breast cancer (BC) mortality is mainly due to metastatic disease, which is primarily driven by cancer stem cells (CSC). The chemokine C-X-C motif ligand-1 (CXCL1) is involved in BC metastasis, but the question of whether it regulates breast cancer stem cell (BCSC) behavior is yet to be explored. Here, we demonstrate that BCSCs express CXCR2 and produce CXCL1, which stimulates their proliferation and self-renewal, and that CXCL1 blockade inhibits both BCSC proliferation and mammosphere formation efficiency. CXCL1 amplifies its own production and remarkably induces both tumor-promoting and immunosuppressive factors, includingSPP1/OPN,ACKR3/CXCR7,TLR4,TNFSF10/TRAILandCCL18and, to a lesser exte…

breast cancer stem cellsQH301-705.5animal diseasesSettore MED/50 - Scienze Tecniche Mediche ApplicatechemokinesBiologyCXCR4MetastasisCell and Developmental Biologyimmunity geneCancer stem cellmedicinetumor microenvironmentCXC chemokine receptorsBiology (General)immunity genesTriple-negative breast cancerTumor microenvironmentbreast cancer stem cellchemokineCell BiologyBrief Research Reportrespiratory systemmedicine.diseaseCXCL1Tumor progressiontriple-negative breast cancerCancer researchCCL28Settore MED/46 - Scienze Tecniche Di Medicina Di LaboratorioDevelopmental BiologyFrontiers in Cell and Developmental Biology
researchProduct

Does autoimmunity play a part in the pathogenesis of glaucoma?

2013

Glaucoma is a chronic neurodegenerative disease and one of the leading causes of blindness. Several risk factors have been described, e.g. an elevated intraocular pressure (IOP), oxidative stress or mitochondrial dysfunction. Additionally, alterations in serum antibody profiles of glaucoma patients, upregulation (e.g. anti-HSP60, anti-MBP) and downregulation (e.g. anti-14-3-3), have been described, but it still remains elusive if the autoantibodies seen in glaucoma are an epiphenomenon or causative. However, it is known that elicited autoimmunity causes retinal ganglion cell loss resulting in glaucomatous-like damage and according to the autoaggressive nature of some autoantibodies we found…

business.industryAutoantibodyGlaucomaAutoimmunityGlaucomaDiseasemedicine.diseasemedicine.disease_causeNeuroprotectionRetinaSensory SystemsAutoimmune DiseasesBiomarker (cell)AutoimmunityPathogenesisDisease Models AnimalOphthalmologyImmunologyProtective autoimmunitymedicineAnimalsHumanssense organsbusinessAutoantibodiesProgress in Retinal and Eye Research
researchProduct

Neuroprotection and autoimmunity in glaucoma

2012

In glaucoma, the elevated intraocular pressure cannot explain the disease in all patients. However, the pathogenesis of the disease is widely unknown. Biomarker research could be help to understand the disease process. Beside some genetic and proteomic biomarkers, immunoproteomics could play a significant role. Several studies could provide hints for an involvement of autoantibodies in the pathogenesis of the disease. The complex profiles of natural occurring autoantibodies were analyzed by Western Blotting and mass spectrometry based techniques combined with multivariate statistics and artificial neural networks. In several studies we could demonstrate consistent up- and down-regulations o…

business.industryAutoantibodyGlaucomaGeneral MedicineDiseasemedicine.diseasemedicine.disease_causeNeuroprotectionImmunoproteomicsAutoimmunityPathogenesisOphthalmologyImmunologyBiomarker (medicine)MedicinebusinessActa Ophthalmologica
researchProduct

Cellul�re Immunreaktionen gegen�ber homologen leberspezifischen Antigenen (HLP) bei chronischen Leberentz�ndungen

1974

Es wird eine Zweiphasentechnik des Leukocyten-Migrations-Inhibitionstestes beschrieben und zum Nachweis einer cellularen Immunreaktion gegenuber Leberantigenen bei chronisch-entzundlichen Lebererkrankungen eingesetzt. Mit dieser Technik wurde bei 85% der Patienten mit hypergammaglobulinamischer Verlaufsform einer chronisch-aktiven Hepatitis und 42% der Patienten mit aktiv fortschreitenden kryptogenen Lebercirrhosen eine Migrationshemmung nachgewiesen. Lebergesunde Kontrollen zeigten keine, Patienten mit dem Zustand nach Hepatitis und chronisch-persistierender Hepatitis selten eine Leukocytenmigrationsinhibition gegenuber leberspezifischen Antigenen. 17% der Patienten mit chronisch-aktiver H…

business.industryCell Migration InhibitionGeneral MedicineMolecular medicineMolecular biologyChronic diseaseAntigenImmunityDrug DiscoveryHomologous chromosomeMolecular MedicineMedicineImmune reactionbusinessGenetics (clinical)Liver immunologyKlinische Wochenschrift
researchProduct

New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting.

1990

business.industryGeneral NeuroscienceImmunityComputational biologyBiologyCellular levelIn Vitro TechniquesLymphocyte ActivationGeneral Biochemistry Genetics and Molecular BiologyBiological FactorsStructure-Activity RelationshipText miningReceptors GlucocorticoidHistory and Philosophy of ScienceHLA AntigensPregnenedionesCytokinesHumansInterferonsLymphocytesbusinessGlucocorticoidsCells Cultured
researchProduct

Modeling a Complex Disease

2011

The recent decades have shown that multiple sclerosis (MS) is not a uniform disease entity with common etiology, but rather a disease or syndrome characterized by a heterogeneous pattern of manifestations and pathological principles. Apart from the older distinctions of the Devic's disease from the standard Western form of relapsing remitting MS or the more Asian form of opticospinal MS, specific pathological patterns indicating distinct etiologies have been established by analyses of biopsies and autopsies. Further, the distinct responses of patients to drugs targeting either specific cell types or immunoregulatory mechanisms such as Rituximab or IFNβ clearly demonstrate the heterogeneity …

business.industryMechanism (biology)Multiple sclerosisNeurodegenerationDiseasemedicine.diseasemedicine.disease_causeAutoimmunityImmunologymedicineEtiologyRituximabbusinessPathologicalNeurosciencemedicine.drug
researchProduct

Heat Shock Proteins in Multiple Sclerosis Pathogenesis: Friend or Foe?

2015

Multiple Sclerosis is a complex chronic inflammatory, neurodegenerative disease conditioned by genetic, epigenetic and environmental factors. Main pathological features of MS include areas of focal demyelination of white matter characterized by gliosis, neuron and oligodendrocyte loss. Neurodegenerative as well as immune-mediated processes play a role in the pathogenesis of this disease. One of these immunogenic factors could be represented by the heat shock proteins. HSP exhibit cytoprotective and cytostimulatory effects due to their molecular chaperones role, in many brain model misfolding diseases such as Alzheimer’s and Parkinson’s diseases, whereas still no unambiguous results have bee…

business.industryMultiple sclerosisCentral nervous systemDiseasemedicine.diseasemedicine.disease_causeOligodendrocyteAutoimmunityPathogenesismedicine.anatomical_structureGliosisAutoimmunity Central nervous system Chaperone activity Demyelination Heat shock proteins Multiple sclerosisHeat shock proteinmedicinemedicine.symptomSettore BIO/06 - Anatomia Comparata E CitologiabusinessNeuroscience
researchProduct

NF-κB in inflammatory bowel disease

2008

Apart from genetic and environmental factors, the mucosal immune system of the gut plays a central role in the pathogenesis of inflammatory bowel disease (IBD). In the healthy gut, the mucosal immune system ensures the balance between pro- and anti-inflammatory mediators and thereby allows an effective defence against luminal pathogens but at the same time prevents an overwhelming immune reaction directed against the huge amount of harmless luminal antigens (for example, components of food or nonpathological bacteria). In both entities of IBD (Crohn's disease and ulcerative colitis) this immunological balance is severely impaired and shifted towards the pro-inflammatory side. The chronic mu…

business.industryNF-κBInflammationmedicine.diseaseInflammatory bowel diseaseUlcerative colitisdigestive system diseasesPathogenesischemistry.chemical_compoundImmune systemchemistryAntigenImmunityImmunologyInternal Medicinemedicinemedicine.symptombusinessJournal of Internal Medicine
researchProduct

Translational Value of CSF and Blood Markers of Autoimmunity and Neurodegeneration

2021

business.industryNeurodegenerationImmunologymedicineBlood markersmedicine.diseasemedicine.disease_causebusinessValue (mathematics)Autoimmunity
researchProduct